from PR Newswire
from PR Newswire
Ironwood Completes $175 Million Debt Offering
January 04, 2013
Ironwood and Forest Announce U.S. Availability of LINZESS™ (Linaclotide)
December 17, 2012
Protagonist and Ironwood Expand Peptide Drug Discovery Collaboration
December 06, 2012
Constella® (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)in Adults
November 28, 2012
from PR Newswire
BioMed Realty Announces 93,000 Square Foot Lease Expansion And Extension With Ironwood Pharmaceuticals At 301 Binney Street
October 31, 2012
from PR Newswire
Ironwood Pharmaceuticals Provides Third Quarter 2012 Investor Update
October 16, 2012
Linaclotide Receives Positive CHMP Opinion for the Treatment of IBS-C
September 21, 2012
VFC's Stock House: Synergy Pharma Positioning For Pipeline Payoff
September 19, 2012
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here